Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target populationChristopher Blaum, Christoph Waldeyer, Fabian J. Brunner et al.|European Journal of Preventive Cardiology|2019Cited by 57
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE projectNatalie Arnold, Christoph Waldeyer, Allan Linneberg et al.|European Heart Journal|2024Cited by 56
Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol– or Apolipoprotein B–Related Risk of Coronary Heart DiseaseNatalie Arnold, Wolfgang Koenig, Christopher Blaum et al.|Journal of the American College of Cardiology|2024Cited by 20
Inflammatory burden, lifestyle and atherosclerotic cardiovascular disease: insights from a population based cohort studyBenjamin Bay, Christoph Waldeyer, Christopher Blaum et al.|Scientific Reports|2023Cited by 6
Lipoprotein (a) and incident coronary heart disease in the community: impact of traditional cardiovascular risk factorsNatalie Arnold, Wolfgang Köenig, Alina Goßling et al.|European Journal of Preventive Cardiology|2025Cited by 2